First Chimeric Antigen Receptor T-Cell Therapy Approved

被引：1
|
作者：
Brower, Vicki
机构：
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2017年 / 109卷 / 11期
关键词：
D O I：
10.1093/jnci/djx251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Chimeric antigen receptor T-cell therapy for solid tumors
    Newick, Kheng
    Moon, Edmund
    Albelda, Steven M.
    MOLECULAR THERAPY-ONCOLYTICS, 2016, 3
  • [22] Empowering chimeric antigen receptor T-cell therapy with CRISPR
    Zhou, Xuanzhu
    BIOTECHNIQUES, 2020, 68 (04) : 169 - 171
  • [23] Chimeric antigen receptor T-cell therapy for breast cancer
    Gharghani, Mighmig Simonian
    Simonian, Miganoosh
    Bakhtiari, Faezeh
    Ghaffari, Mozhan Haji
    Fazli, Ghazaleh
    Bayat, Ali Ahmad
    Negahdari, Babak
    FUTURE ONCOLOGY, 2021, 17 (22) : 2961 - 2979
  • [24] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Wang, Zehua
    Chen, Chen
    Wang, Lei
    Jia, Yongxu
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [26] Mechanisms of failure of chimeric antigen receptor T-cell therapy
    Li, Xiaoqing
    Chen, Weihong
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (06) : 427 - 433
  • [27] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Hosen, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
  • [28] Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
    Sur, Daniel
    Havasi, Andrei
    Cainap, Calin
    Samasca, Gabriel
    Burz, Claudia
    Balacescu, Ovidiu
    Lupan, Iulia
    Deleanu, Diana
    Irimie, Alexandru
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [29] NURSING IMPLICATIONS OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
    Hansen, Brenna
    Cotton, Stephanie
    Brudno, Jennifer
    Kochenderfer, James
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [30] Chimeric antigen receptor T-cell therapy hits the market
    Boyer, Michael W.
    IMMUNOTHERAPY, 2018, 10 (11) : 911 - 912
12345